89 related articles for article (PubMed ID: 32779195)
21. [Neurological impairment in children with HIV infection].
Orejón de Luna G; Mateos F; Simón de las Heras R; Martínez Menéndez B; Ramos Amador JT; Muñoz González A
Rev Neurol; 1996 Mar; 24(127):278-84. PubMed ID: 8742389
[TBL] [Abstract][Full Text] [Related]
22. Comparison of developmental milestone attainment in early treated HIV-infected infants versus HIV-unexposed infants: a prospective cohort study.
Benki-Nugent S; Wamalwa D; Langat A; Tapia K; Adhiambo J; Chebet D; Okinyi HM; John-Stewart G
BMC Pediatr; 2017 Jan; 17(1):24. PubMed ID: 28095807
[TBL] [Abstract][Full Text] [Related]
23. Clinical and neuroimaging profile of HIV-1 encephalopathy in infancy and childhood in a sub-Saharan African country.
G Mariam A; Assefa G
Ethiop Med J; 2012 Oct; 50(4):337-47. PubMed ID: 23930479
[TBL] [Abstract][Full Text] [Related]
24. Effect of HIV-1 low-level viraemia during antiretroviral therapy on treatment outcomes in WHO-guided South African treatment programmes: a multicentre cohort study.
Hermans LE; Moorhouse M; Carmona S; Grobbee DE; Hofstra LM; Richman DD; Tempelman HA; Venter WDF; Wensing AMJ
Lancet Infect Dis; 2018 Feb; 18(2):188-197. PubMed ID: 29158101
[TBL] [Abstract][Full Text] [Related]
25. HIV-associated CD4+/CD8+ depletion in infancy is associated with neurometabolic reductions in the basal ganglia at age 5 years despite early antiretroviral therapy.
Mbugua KK; Holmes MJ; Cotton MF; Ratai EM; Little F; Hess AT; Dobbels E; Van der Kouwe AJ; Laughton B; Meintjes EM
AIDS; 2016 Jun; 30(9):1353-62. PubMed ID: 26959509
[TBL] [Abstract][Full Text] [Related]
26. Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy in Perinatally HIV-Infected, Treatment-Naïve Adolescents in Asia.
Boettiger DC; Sudjaritruk T; Nallusamy R; Lumbiganon P; Rungmaitree S; Hansudewechakul R; Kumarasamy N; Bunupuradah T; Saphonn V; Truong KH; Yusoff NKN; Do VC; Nguyen LV; Razali KAM; Fong SM; Kurniati N; Kariminia A
J Adolesc Health; 2016 Apr; 58(4):451-459. PubMed ID: 26803201
[TBL] [Abstract][Full Text] [Related]
27. [Course and treatment of progressive subacute encephalopathy caused by human immunodeficiency virus in children. The value of Botulinum toxin].
Noguera-Julian A; Pérez-Dueñas B; Fortuny-Guasch C; López-Casas J; Póo P
Rev Neurol; 2004 Feb 1-15; 38(3):239-43. PubMed ID: 14963851
[TBL] [Abstract][Full Text] [Related]
28. Neurological and developmental effects of HIV and AIDS in children and adolescents.
Mitchell W
Ment Retard Dev Disabil Res Rev; 2001; 7(3):211-6. PubMed ID: 11553937
[TBL] [Abstract][Full Text] [Related]
29. Regression of attained milestones in an HIV infected infant.
Madhivanan P; Mothi SN; Kumarasamy N; Yepthomi T; Lambert J; Solomon S
Indian J Pediatr; 2001 Oct; 68(10):991-3. PubMed ID: 11758142
[TBL] [Abstract][Full Text] [Related]
30. [Acquired immunodeficiency syndrome by vertical transmission: neurological disorders].
Tellechea-Rotta N; Legido A
Rev Neurol; 2003 Feb 1-15; 36(3):255-63. PubMed ID: 12599156
[TBL] [Abstract][Full Text] [Related]
31. Long-term trends in mortality and AIDS-defining events after combination ART initiation among children and adolescents with perinatal HIV infection in 17 middle- and high-income countries in Europe and Thailand: A cohort study.
; Judd A; Chappell E; Turkova A; Le Coeur S; Noguera-Julian A; Goetghebuer T; Doerholt K; Galli L; Pajkrt D; Marques L; Collins IJ; Gibb DM; González Tome MI; Navarro M; Warszawski J; Königs C; Spoulou V; Prata F; Chiappini E; Naver L; Giaquinto C; Thorne C; Marczynska M; Okhonskaia L; Posfay-Barbe K; Ounchanum P; Techakunakorn P; Kiseleva G; Malyuta R; Volokha A; Ene L; Goodall R
PLoS Med; 2018 Jan; 15(1):e1002491. PubMed ID: 29381702
[TBL] [Abstract][Full Text] [Related]
32. HIV-associated neurodevelopmental delay: prevalence, predictors and persistence in relation to antiretroviral therapy initiation and viral suppression.
Strehlau R; Kuhn L; Abrams EJ; Coovadia A
Child Care Health Dev; 2016 Nov; 42(6):881-889. PubMed ID: 27546069
[TBL] [Abstract][Full Text] [Related]
33. Treatment Failure in HIV-Infected Children on Second-line Protease Inhibitor-Based Antiretroviral Therapy.
Suaysod R; Ngo-Giang-Huong N; Salvadori N; Cressey TR; Kanjanavanit S; Techakunakorn P; Krikajornkitti S; Srirojana S; Laomanit L; Chalermpantmetagul S; Lallemant M; Le Cœur S; McIntosh K; Traisathit P; Jourdain G
Clin Infect Dis; 2015 Jul; 61(1):95-101. PubMed ID: 25838288
[TBL] [Abstract][Full Text] [Related]
34. [Encephalopathy in children infected by vertically transmitted human immunodeficiency virus].
Czornyj LA
Rev Neurol; 2006 Jun 16-30; 42(12):743-53. PubMed ID: 16775801
[TBL] [Abstract][Full Text] [Related]
35. [Clinical and virological correlation between the cerebrospinal fluid and blood of HIV-infected children].
Sáez-Llorens X; Castrejón de Wong MC; Castaño E; de Suman O; Báez de Ulloa C; Redondo W; Espino M
Rev Med Panama; 2001; 26():13-8. PubMed ID: 16161718
[TBL] [Abstract][Full Text] [Related]
36. Initial response to protease-inhibitor-based antiretroviral therapy among children less than 2 years of age in South Africa: effect of cotreatment for tuberculosis.
Reitz C; Coovadia A; Ko S; Meyers T; Strehlau R; Sherman G; Kuhn L; Abrams EJ
J Infect Dis; 2010 Apr; 201(8):1121-31. PubMed ID: 20214476
[TBL] [Abstract][Full Text] [Related]
37. Evidence for extended age dependent maternal immunity in infected children: mother to child transmission of HIV infection and potential interventions including sulfatides of the human fetal adnexa and complementary or alternative medicines.
Bhargav H; Huilgol V; Metri K; Sundell IB; Tripathi S; Ramagouda N; Jadhav M; Raghuram N; Ramarao NH; Koka PS
J Stem Cells; 2012; 7(3):127-53. PubMed ID: 23619381
[TBL] [Abstract][Full Text] [Related]
38. Correlating brain volume and callosal thickness with clinical and laboratory indicators of disease severity in children with HIV-related brain disease.
Andronikou S; Ackermann C; Laughton B; Cotton M; Tomazos N; Spottiswoode B; Mauff K; Pettifor JM
Childs Nerv Syst; 2014 Sep; 30(9):1549-57. PubMed ID: 24853332
[TBL] [Abstract][Full Text] [Related]
39. Rapid decline of HIV-1 DNA and RNA in infants starting very early antiretroviral therapy may pose a diagnostic challenge.
Veldsman KA; Maritz J; Isaacs S; Katusiime MG; Janse van Rensburg A; Laughton B; Mellors JW; Cotton MF; van Zyl GU
AIDS; 2018 Mar; 32(5):629-634. PubMed ID: 29334551
[TBL] [Abstract][Full Text] [Related]
40. Spastic diplegia in children with HIV encephalopathy: first description of gait and physical status.
Langerak NG; du Toit J; Burger M; Cotton MF; Springer PE; Laughton B
Dev Med Child Neurol; 2014 Jul; 56(7):686-94. PubMed ID: 24182356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
